Linda Rubinstein

Ms. Rubinstein has been a partner at FLG Partners since 2010. She has over 30 years of operational, financial, and capital markets experience and has been CFO of numerous public and private companies. While at FLG, Ms. Rubinstein has served as the permanent or interim CFO of Apexigen, ArmaGen, Five Prime, Ingenuity, iPierian, Kezar, PaxVax, Retrotope, Sublimity, True North, and Tunitas, among others. Ms. Rubinstein also has held various positions at life science companies and investment banks, including Solexa, a public genetic analysis instrumentation company, ChemoCentryx, a biotechnology company, RDJ Advisors, a financial and strategic consulting firm, and Lehman Brothers. Ms. Rubinstein received her M.A. and B.A. degrees in Economics from the University of California, Los Angeles.